Suppr超能文献

蛇床子素治疗动物高脂血症和酒精性脂肪肝的实验研究

Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.

作者信息

Song Fang, Xie Mei-Lin, Zhu Lu-Jia, Zhang Ke-Ping, Xue Jie, Gu Zhen-Lun

机构信息

Department of Pharmacology, Medical School of Soochow University, Suzhou 215123, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2006 Jul 21;12(27):4359-63. doi: 10.3748/wjg.v12.i27.4359.

Abstract

AIM

To evaluate the effects of osthole on fatty liver, and investigate the possible mechanism.

METHODS

A quail model with hyperlipidemic fatty liver and rat model with alcoholic fatty liver were set up by feeding high fat diet and alcohol, respectively. These experimental animals were then treated with osthole 5-20 mg/kg for 6 wk, respectively. Whereafter, the lipid in serum and hepatic tissue, and coefficient of hepatic weight were measured.

RESULTS

After treatment with osthole the levels of serum total cholesterol (TC), triglyceride (TG), lower density lipoprotein-cholesterol (LDL-C), coefficient of hepatic weight, and the hepatic tissue contents of TC and TG were significantly decreased. The activity of superoxide dismutase (SOD) in liver was improved. In alcohol-induced fatty liver rats, the level of malondialdehyde (MDA) in liver was decreased. In high fat-induced fatty liver quails, glutathione peroxidase (GSH-PX) in liver was significantly improved. The histological evaluation of liver specimens demonstrated that the osthole dramatically decreased lipid accumulation.

CONCLUSION

These results suggested that osthole had therapeutic effects on both alcohol and high fat-induced fatty liver. The mechanism might be associated with its antioxidation.

摘要

目的

评估蛇床子素对脂肪肝的影响,并探讨其可能的作用机制。

方法

分别通过高脂饮食和酒精喂养建立高脂血症脂肪肝鹌鹑模型和酒精性脂肪肝大鼠模型。然后分别用5 - 20mg/kg蛇床子素对这些实验动物进行6周治疗。之后,测定血清和肝组织中的脂质以及肝重系数。

结果

蛇床子素治疗后,血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL - C)水平、肝重系数以及肝组织中TC和TG含量均显著降低。肝脏中超氧化物歧化酶(SOD)活性得到改善。在酒精性脂肪肝大鼠中,肝脏中丙二醛(MDA)水平降低。在高脂性脂肪肝鹌鹑中,肝脏中谷胱甘肽过氧化物酶(GSH - PX)显著改善。肝脏标本的组织学评估表明,蛇床子素显著降低了脂质蓄积。

结论

这些结果表明,蛇床子素对酒精性和高脂性脂肪肝均有治疗作用。其机制可能与其抗氧化作用有关。

相似文献

1
Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.
World J Gastroenterol. 2006 Jul 21;12(27):4359-63. doi: 10.3748/wjg.v12.i27.4359.
2
Inhibitory effect of osthole on alcohol-induced fatty liver in mice.
Dig Liver Dis. 2009 Feb;41(2):127-33. doi: 10.1016/j.dld.2008.01.011. Epub 2008 Mar 12.
3
Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress.
Phytother Res. 2011 May;25(5):638-43. doi: 10.1002/ptr.3315. Epub 2010 Oct 27.
4
Therapeutic effect of osthole on hyperlipidemic fatty liver in rats.
Acta Pharmacol Sin. 2007 Mar;28(3):398-403. doi: 10.1111/j.1745-7254.2007.00533.x.
8
Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Arch Pharm Res. 2012 Jul;35(7):1241-50. doi: 10.1007/s12272-012-0715-5. Epub 2012 Aug 3.
10
Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia.
J Ethnopharmacol. 2014 Feb 3;151(2):970-4. doi: 10.1016/j.jep.2013.12.010. Epub 2013 Dec 14.

引用本文的文献

2
The Effect of Osthole on Transient Receptor Potential Channels: A Possible Alternative Therapy for Atopic Dermatitis.
J Inflamm Res. 2024 Feb 9;17:881-898. doi: 10.2147/JIR.S425978. eCollection 2024.
3
6
Application of Metabolomics in the Study of Natural Products.
Nat Prod Bioprospect. 2018 Aug;8(4):321-334. doi: 10.1007/s13659-018-0175-9. Epub 2018 Jun 29.
7
Metabolic map of osthole and its effect on lipids.
Xenobiotica. 2018 Mar;48(3):285-299. doi: 10.1080/00498254.2017.1306660. Epub 2017 Apr 3.
8
9
10
Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.
Evid Based Complement Alternat Med. 2015;2015:919616. doi: 10.1155/2015/919616. Epub 2015 Jul 13.

本文引用的文献

1
Nonalcoholic fatty liver disease in developing countries.
World J Gastroenterol. 2005 Jun 28;11(24):3808-9. doi: 10.3748/wjg.v11.i24.3808.
2
Nonalcoholic fatty liver disease: a review of current understanding and future impact.
Clin Gastroenterol Hepatol. 2004 Dec;2(12):1048-58. doi: 10.1016/s1542-3565(04)00440-9.
3
Clinical features and risk factors of patients with fatty liver in Guangzhou area.
World J Gastroenterol. 2004 Mar 15;10(6):899-902. doi: 10.3748/wjg.v10.i6.899.
4
Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.
QJM. 2003 Oct;96(10):699-709. doi: 10.1093/qjmed/hcg120.
5
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.
Hepatology. 2003 May;37(5):1202-19. doi: 10.1053/jhep.2003.50193.
6
AGA technical review on nonalcoholic fatty liver disease.
Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.
7
Non-alcoholic fatty liver disease.
J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S186-90. doi: 10.1046/j.1440-1746.17.s1.10.x.
8
Nonalcoholic steatohepatitis.
Gastroenterology. 2001 Sep;121(3):710-23. doi: 10.1053/gast.2001.27126.
9
Alcoholic liver disease.
Postgrad Med J. 2000 May;76(895):280-6. doi: 10.1136/pmj.76.895.280.
10
Prevalence of and risk factors for hepatic steatosis in Northern Italy.
Ann Intern Med. 2000 Jan 18;132(2):112-7. doi: 10.7326/0003-4819-132-2-200001180-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验